Logo
Int J High Risk Behav Addict

Image Credit:Int J High Risk Behav Addict

Lifetime, Last Month and Excessive Prevalence of Addictive Substances Consumption Among the General Population and University Students in the City of Tehran

Author(s):
Rouhollah SarollahiRouhollah Sarollahi1, Amir GhaderiAmir Ghaderi1, Hamid Reza BanafsheHamid Reza Banafshe1, Mohammad Ali AtlasiMohammad Ali AtlasiMohammad Ali Atlasi ORCID2,*
1Department of Addiction Studies, School of Medicine, Kashan University of Medical Sciences, Kashan, IR Iran
2Anatomical Sciences Research Center, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, IR Iran

International Journal of High Risk Behaviors and Addiction:Vol. 14, issue 3; e159843
Published online:Jul 30, 2025
Article type:Research Article
Received:Jan 21, 2025
Accepted:Jul 21, 2025
How to Cite:Sarollahi R, Ghaderi A, Banafshe H R, Atlasi M A. Lifetime, Last Month and Excessive Prevalence of Addictive Substances Consumption Among the General Population and University Students in the City of Tehran.Int J High Risk Behav Addict.2025;14(3):e159843.https://doi.org/10.5812/ijhrba-159843.

Abstract

Background:

The lack of epidemiological data over the past decade among Iranians and the inadequate conceptualization of substance consumption prevalence are two targeted problems.

Objectives:

The present research attempts to discriminate between lifetime, last month, and excessive prevalence of addictive substances consumption among the general population and university students and to follow up on public parks as high-risk environments.

Patients and Methods:

This cross-sectional and partially longitudinal study was conducted in Tehran during the fall of 2023 and 2024. A total of 2,183 valid participants were recruited by distributing 15,500 flyers containing a weblink and barcode to an online questionnaire assessing the experience, frequency, and initiation age of various substances consumption. Pearson's chi-squared test with Yates' continuity correction and Welch two sample t-test performed with R were used for statistical analysis.

Results:

Lifetime prevalence among the general population was as follows: Hookah (57.3%), cigarettes (54.4%), alcohol (41.9%), marijuana (16.0%), psychiatrics (12.5%), opium (7.5%), hashish (4.5%), crystal (1.6%), heroin (1.6%), LSD (1.3%), and ecstasy (1.1%). The highest priorities for last month prevalence are cigarettes (32.0%), alcohol (20.5%), hookah (17.6%), and marijuana (4.6%). Cigarettes had the highest excessive prevalence (8.5%), followed by hookah (2.7%) and alcohol (2.7%). The prevalence of almost all substances was significantly higher, and the age of initiation was lower in public parks compared to the general population (alpha < 0.01), and there was a notable enthusiasm for stimulant drugs. Despite the increase in prevalence for all substances through the public parks after one year follow-up, the lifetime prevalence of marijuana changed the most significantly (10 percentage points with P = 0.011). University students behave like the general population, except for the lower prevalence of hard drugs and the lack of a gender difference for cigarettes, alcohol, and psychiatrics.

Conclusions:

Considering the medical consequences of excessive consumption, tobacco cigarettes are the most malignant problem, but marijuana, with its accelerating prevalence, is the immediate challenge. The role of public parks as the market base points to the need for legalization of addictive behaviors and an economic paradigm shift to prevent a social catastrophe. The gender similarity among students hints at a cultural reformation rooted in universities jeopardized femininity.

1. Background

Addiction, as a pleasure-seeking dysfunction characterized by tolerance and relapse, is one of the most pervasive and enduring health problems in societies (1). Confronting denial as the first obstacle to such an intangibly contagious phenomenon spreading in the underbelly of society is not possible without constant active surveillance. Yet, not only is there no such routine procedure in the Iranian national health system, there has not been a single independent epidemiological report for a decade. The two latest reports were conducted almost simultaneously in 2013, both surveying university students and revealing the lifetime prevalence of hookah (24.0% and 14.9%), cigarettes (17.0% and 26.3%), alcohol (13.0% and 19.9%), and marijuana (5.2% and 7.1%) in Jahrom and Tehran, respectively. The first article reported only the age of first consumption for all types of substances (16.5 ± 3.6 years for males and 17.3 ± 3.6 years for females with P > 0.05), and the second article reported two ages of first consumption for cigarettes (18.33 years) and alcohol (18.6 years) without standard deviation and gender distinction. The reported frequency of consumption is ambiguous and misclassified. In the first study, the frequency is differentiated by the two titles of occasional and sustained usage without specifying quantitative criteria that are considerable for hookah (5.1% and 4.1%), cigarettes (2.5% and 4.1%), and alcohol (2.3% and 2.9%). The other article noted an everyday prevalence which is considerable for cigarettes (8.5%), alcohol (3.1%), and marijuana (0.5%). In addition, the second article mentioned the gender similarity for cigarettes and alcohol (2, 3).

The prevalence of addictive substances consumption, usually referred to as lifetime prevalence, is an inadequate concept that includes all individuals who have used a substance at least once in their whole life. While this broad concept is informative as it indicates the penetration coefficient of a substance, it does not reflect the addictive aspect of consumption at all. The frequency of consumption repetition, which is pivotal for capturing the social conditions of addictive behavior, was omitted from lifetime prevalence, and attempts to conceptualize it led to vague results. A misunderstanding of reality can be avoided by asking a single quantitative Likert-scale question about the frequency of consumption in a given period. Using the last month as an achievable time period for estimating consumption frequency, this study attempts to discriminate between three cumulative definitions for addictive substance consumption prevalence:

- Lifetime prevalence: Includes whoever has used a substance at least once in their whole life.

- Last month prevalence: Includes whoever has used a substance at least once in the last month.

- Excessive prevalence: Includes levels higher than the cut-off in a Likert-scale variable that measures the last month consumption frequency.

2. Patients and Methods

An online short questionnaire designed by the researcher surveyed three demographic items (gender, year of birth, and university/occupation); one to three questions depending on the first answer for each of the seven substances: Hookah, cigarettes, alcohol, marijuana, hashish, opium, and psychiatrics (any effective drug on the mind, taken without prescription, such as Tramadol, Zolpidem, Ritalin, Clonazepam, Diazepam, etc.), including lifetime experience, the year of first consumption, and a Likert-scale question about the last month consumption frequency (Table 1); and only one question on lifetime experience with each of the four substances: The LSD, ecstasy, crystal, and heroin. The preservation of anonymity, the necessity for the participation of nonusers, and the ethical approval of the research were expressed on the first page of the questionnaire and concluded with obtaining informed consent. The study protocol was approved according to the code of ethics IR.KAUMS.MEDNT.REC.1401.015.

Table 1.Ascending Descriptions for Consumption Frequency in the Last Month Corresponding to Each Substance
VariablesLifetime Prevalence
Last Month Prevalence
Excessive Prevalence
Hookah No consumptionOnceTwo to four timesUp to eight timesMore than eight times
CigarettesNo consumptionLess than a packUp to three packsUp to ten packsMore than ten packs
Alcohol No consumptionOnceTwo or three timesUp to ten timesMore than ten times
Marijuana No consumptionOnceTwo or three timesUp to ten timesMore than ten times
PsychiatricsNo consumptionOnce or twiceUp to five timesUp to ten timesMore than ten times
OpiumNo consumptionOnceTwo or three timesUp to ten timesMore than ten times
HashishNo consumptionOnceTwo or three timesUp to ten timesMore than ten times

Ascending Descriptions for Consumption Frequency in the Last Month Corresponding to Each Substance

People were invited to participate in the research through non-probabilistic voluntary sampling by distributing flyers containing a brief explanation, the weblink and associated barcode to the online questionnaire, and a request to share. The preservation of anonymity and the necessity for the participation of nonusers were also noted in the flyers. In the fall of 2023, 5,000 flyers were distributed on university campuses among students of the University of Tehran (UT) and Tehran University of Medical Sciences (TUMS), and 3,000 flyers were distributed among people in public parks from different socioeconomic areas in Tehran (two sampling biases were excluded: Special parks that are illustrious centers for consumer gatherings were intentionally avoided, and older people were ignored with an excuse). In the fall of 2024, 4,500 flyers were distributed in the same way in public parks, and 3,000 flyers were distributed among the general population at subway entrances from different socioeconomic areas in Tehran. To prepare the results, rows with inconsistent data, such as the start of consumption before birth, were completely excluded. Furthermore, when comparing gender-specific differences, the category "others" beyond the binary categories "females" (F) and "males" (M) was excluded, as the number of this group is very small, which makes statistical analysis meaningless.

2.1. Participants

1. The UT and TUMS students (Fall 2023): 1,105 Persons (898 UT, 207 TUMS), (gender: Fifty percent females, 49% males, 1% others; age = 17 - 42 years; mean ± SD = 22 ± 3.5 years)

2. Public parks (Fall 2023): 252 Persons [gender: Forty percent females, 58% males, 2% others; age = 15 - 46 years; mean ± SD = 25 ± 7.8 years), (includes 89 university students (gender: Sixty percent females, 37% males, 3% others; age = 16 - 39 years; mean ± SD = 22 ± 3.4 years)]

3. Public parks (Fall 2024): 451 Persons [gender: Thirty-six percent females, 63% males, 1% others; age = 14 - 45 years; mean ± SD = 25 ± 6.1 years), (includes 118 university students (gender: Fifty-two percent females, 46% males, 2% others; age = 18 - 36 years; mean ± SD = 22 ± 3.1 years)]

4. Subway entrances (Fall 2024): 375 Persons [gender: Fifty-seven percent females, 42% males, 1% others; age = 15 - 61 years; mean ± SD = 26 ± 8.9 years), (includes 164 university students (gender: Fifty-four percent females, 46% males, 0% others; age = 18 - 35 years; mean ± SD = 22 ± 3.0 years)]

2.2. Statistical Analysis

Prevalence rates were compared between groups using Pearson's chi-squared test with Yates' continuity correction. The age of first consumption was compared between groups using the Welch Two Sample t-test. All procedures were performed with R.

3. Results

The results are presented in five tables: Results from university students sampled on campus and the general population sampled at the subway entrances (Table 2), comparison of the general population at the subway entrances and the public parks sample (Table 3), longitudinal comparison of the public parks results (Table 4), results comparing gender differences (Table 5), and results from university students from different sample groups (Table 6). Noticeable results have been reviewed in the Discussion section.

Table 2.Results from University Students Sampled on Campus and the General Population Sampled at the Subway Entrances a
VariablesUT and TUMS Students (Fall 2023)General Population at Subway Entrances (Fall 2024)
LifetimeLast MonthExcessiveStart AgeLifetimeLast MonthExcessiveStart Age
Hookah 45.412.51.517 ± 457.317.62.718 ± 6
Cigarettes50.934.210.718 ± 354.432.08.519 ± 6
Alcohol 37.820.53.618 ± 341.920.52.720 ± 6
Marijuana 15.35.31.320 ± 316.04.31.922 ± 5
Psychiatrics10.02.81.019 ± 412.53.71.624 ± 8
Opium2.50.40.019 ± 77.52.90.522 ± 6
Hashish2.40.50.220 ± 34.50.50.321 ± 4
LSD1.1---1.3---
Ecstasy0.2---1.1---
Crystal0.4---1.6---
Heroin 0.2---1.6---

Results from University Students Sampled on Campus and the General Population Sampled at the Subway Entrances a

Table 3.Comparison of the General Population at the Subway Entrances and the Public Parks Sample a
VariablesSubway Entrances vs. Public Parks (Fall 2024)
LifetimeLast MonthExcessiveStart Age
SubParksP-ValueSubParksP-ValueSubParksP-ValueSubParksP-Value
Hookah 57.374.00.00017.628.90.0672.74.90.37918 ± 616 ± 50.000
Cigarettes54.471.10.00032.053.10.0008.528.40.00019 ± 617 ± 50.000
Alcohol 41.964.20.00020.540.70.0042.710.70.00420 ± 618 ± 50.000
Marijuana 16.039.60.0004.318.20.0121.912.40.00322 ± 519 ± 50.002
Psychiatrics12.522.70.0003.77.80.7051.64.20.43424 ± 820 ± 50.009
Opium7.514.90.0012.94.20.3050.52.4-22 ± 620 ± 60.125
Hashish4.517.10.0000.54.4-0.31.1-21 ± 419 ± 60.165
LSD1.38.40.000---------
Ecstasy1.16.20.000---------
Crystal1.65.30.011---------
Heroin1.62.90.270---------

Comparison of the General Population at the Subway Entrances and the Public Parks Sample a

Table 4.Longitudinal Comparison of the Public Parks Results a
VariablesPublic Parks (Fall 2023 vs. Fall 2024)
LifetimeLast MonthExcessiveStart Age
20232024P-Value20232024P-Value20232024P-Value20232024P-Value
Hookah 68.474.00.18317.228.90.0053.64.90.87817 ± 916 ± 50.150
Cigarettes67.271.10.29146.053.10.21522.828.40.01817 ± 1117 ± 50.275
Alcohol 58.064.20.14130.840.70.0555.210.70.05518 ± 1018 ± 50.799
Marijuana 29.639.60.01112.018.20.4638.012.40.67120 ± 519 ± 50.384
Psychiatrics20.822.70.7186.47.80.8582.04.20.26922 ± 620 ± 50.157
Opium13.214.90.7013.24.20.9360.82.4-22 ± 620 ± 60.089
Hashish14.417.10.4752.04.40.2751.21.1-20 ± 519 ± 60.306
LSD7.28.40.757---------
Ecstasy5.26.20.807---------
Crystal4.05.30.646---------
Heroin 2.82.91---------

Longitudinal Comparison of the Public Parks Results a

Table 5.Results Comparing Gender Differences a
VariablesLifetimeLast MonthExcessiveStart Age
FMPFMPFMPFMP
UT and TUMS Students (Fall 2023)
Hookah45.412.51.517 ± 4
41.449.60.00810.115.10.1571.31.7-17.116.10.008
Cigarettes50.934.210.718 ± 3
50.850.20.88430.337.30.0006.914.70.00018.317.70.047
Alcohol37.820.53.618 ± 3
37.337.1119.520.90.4653.14.1-18.917.80.001
Marijuana15.35.31.320 ± 3
11.718.30.0033.46.70.4110.71.7-20.219.90.587
Psychiatrics10.02.81.019 ± 4
9.210.10.6943.22.20.2061.10.9-19.518.60.307
Opium2.50.40.019 ± 7
1.33.90.0100.20.6-0.00.0-17.918.80.812
Hashish2.40.50.220 ± 3
0.93.70.0030.20.6-0.20.2-20.219.40.632
Students from Subway Entrances
Hookah68.417.23.617 ± 9
62.473.10.10015.818.613.04.1-16.616.90.862
Cigarettes67.246.022.817 ± 11
64.468.30.61440.649.70.25712.929.70.00217.615.80.332
Alcohol58.030.85.218 ± 10
57.458.60.95629.731.70.9122.07.60.10118.217.50.699
Marijuana29.612.08.020 ± 5
19.836.60.0077.914.513.011.70.24420.919.90.517
Psychiatrics20.86.42.022 ± 6
12.926.90.0135.96.9-1.02.8-20.821.80.608
Opium13.23.20.822 ± 6
3.020.70.0001.04.8-0.01.4-17.322.30.020
Hashish14.42.01.220 ± 5
3.022.80.0000.03.5-0.02.1-22.720.30.661
Subway entrances (Fall 2024)
Hookah57.32.717.618 ± 6
52.363.50.04013.522.60.1631.43.8-18.217.70.507
Cigarettes54.432.08.519 ± 6
48.162.30.00923.842.10.0132.815.70.00020.618.10.002
Alcohol41.920.52.720 ± 6
34.152.20.00113.629.60.0521.93.8-21.518.00.000
Marijuana16.04.31.922 ± 5
10.322.70.0022.36.3-0.92.5-22.021.80.824
Psychiatrics12.53.71.624 ± 8
9.815.10.1653.33.80.7751.41.3-25.522.50.255
Opium7.52.90.522 ± 6
1.914.50.0000.56.3-0.01.3-23.821.50.653
Hashish4.50.50.321 ± 4
2.36.90.0570.00.6-0.00.0-21.420.90.851
Public parks (Fall 2024)
Hookah74.028.94.916 ± 5
69.876.10.17922.831.70.1442.56.00.19816.115.50.347
Cigarettes71.153.128.417 ± 5
66.773.20.17442.059.20.00119.133.50.00518.217.20.102
Alcohol64.240.710.718 ± 5
61.765.50.48736.443.00.3306.213.00.04718.417.10.057
Marijuana39.618.212.419 ± 5
25.347.90.0006.824.70.0013.717.30.01620.019.40.506
Psychiatrics22.77.84.220 ± 5
16.026.40.0174.39.50.5462.54.9-19.420.40.436
Opium14.94.22.420 ± 6
5.620.10.0001.25.6-0.63.2-18.220.00.406
Hashish17.14.41.119 ± 6
4.923.90.0001.26.0-0.61.1-17.919.50.460

Results Comparing Gender Differences a

Table 6.Results from University Students from Different Sample Groups a
VariablesLifetimeLast MonthExcessiveStart Age
UT and TUMS Students
Hookah45.412.51.517 ± 4
Cigarettes50.934.210.718 ± 3
Alcohol37.820.53.618 ± 3
Marijuana15.35.31.320 ± 3
Psychiatrics10.02.81.019 ± 4
Opium2.50.40.019 ± 7
Hashish2.40.50.220 ± 3
Students from public parks (Fall 2023)
Hookah 62.912.40.017 ± 4
Cigarettes67.444.916.918 ± 3
Alcohol 49.423.64.518 ± 4
Marijuana23.611.25.620 ± 4
Psychiatrics14.65.61.119 ± 3
Opium2.21.11.118 ± 0
Hashish4.52.31.118 ± 1
Students from Subway Entrances (Fall 2024)
Hookah47.011.60.016 ± 3
Cigarettes47.625.64.918 ± 3
Alcohol33.514.01.218 ± 4
Marijuana11.64.30.619 ± 2
Psychiatrics7.32.40.618 ± 3
Opium1.81.20.020 ± 8
Hashish1.80.60.019 ± 5
Students from public parks (Fall 2024)
Hookah64.426.32.515 ± 4
Cigarettes63.639.018.617 ± 3
Alcohol49.228.85.117 ± 3
Marijuana24.67.64.219 ± 2
Psychiatrics11.04.22.519 ± 4
Opium3.40.00.019 ± 1
Hashish4.20.00.017 ± 3

Results from University Students from Different Sample Groups a

4. Discussion

Different prevalences sort different criteria for prioritizing problematic consumption. Although lifetime prevalence ranks hookah higher than tobacco cigarettes, there is no competitor for cigarettes when looking at last month and excessive prevalence. Compared to illicit substances, social acceptance and legal endorsement are likely the causes of pervasive consumption of cigarettes, but compared to hookah, accessibility and ease of preparation lead to the high last month and excessive prevalence of cigarettes. An international comparison of World Health Organization (WHO) data for current tobacco consumption in the whole world and Eastern Mediterranean regions, which are 20.9% and 17.9% respectively (4), with our comparable last month prevalence, which is 32.0%, raises serious caution and calls for a cross-cultural investigation to determine the causes of this large discrepancy between our society and global averages. Looking at the medical consequences of excessive consumption, tobacco cigarettes are the most malignant problem in the health system, accounting for 8.5%.

The next three priorities after tobacco are alcohol, marijuana, and psychiatrics. Comparing our data for lifetime and excessive prevalence of alcohol, which are 41.9% and 2.7%, respectively, with the WHO figures for the whole world and Eastern Mediterranean regions, which are 80.0%, 38.0%, 2.3%, and 0.3% for lifetime prevalence and dependence on alcohol, respectively (5), raises concerns about excessive alcohol consumption in our population if excessive prevalence is a reasonable equivalent for dependence. Despite the lower prevalence of marijuana compared to cigarettes and alcohol, the accelerated increase in the use of marijuana is at the forefront of challenges that require immediate solutions and action. An international comparison of cannabis prevalence seems absurd due to the rapidly evolving conditions and diverse sociopolitical struggles over legalization. This worldwide ambiguity, reflected in systematic reviews (6, 7), specifies the requirements for plural indigenous action plans for an irregular multifaceted approach to the world's most commonly used drug, which accounts for an estimated 41% of drug use disorder cases globally (8). Regarding the third priority after tobacco, addictiveness is the salient feature of psychiatrics. The ratio of excessive to lifetime prevalence sorts substances according to the likelihood of progression from initial consumption to addiction. Addictiveness of substances among the general population lies with cigarettes (16%), psychiatrics (13%), marijuana (12%), alcohol (6%), and hookah (5%).

Even though the sampling avoided specific parks that are illustrious centers for consumer gatherings, highly significant differences between the public parks sample and the general population sampled at subway entrances leave no doubt that public parks are high-risk environments. The statistical test for the one-year follow-up indicates the most significant increase for marijuana as a flagship (10 percentage points increase for lifetime prevalence in just one year with P = 0.011), but the apparent pattern of alteration for all substances depicts the efficiency and prosperity of the market. The role of public parks as the base of the illicit substance market may be the expected consequence of similar incentives for park visits and substance consumption to reduce anxiety and seek pleasure. The common rewards have already lost the unfair economic competition with addictive substances, especially in environmental contexts where drug supply is abundant and cheap, while alternative reinforcers are scarce, expensive, or weak (9). The accomplished supply chain from suppliers and consumers to the securities and officials who are either incompetent or profitable confirms the necessity for the legalization of addictive behaviors to prevent a social catastrophe (10). Neither criminalization nor decriminalization is a solution to restrain the avidity tolerance of addiction within the framework of supply and demand. Only market preemption, advertisement prohibition, harm reduction, self-monitoring promotion, and continuous manipulation to establish an enclosed, controlled market might interpret legalization as a cure, which are paternalistic taboos in a free market economy. But the poor spirits need to belong within their society, not just trade in its markets; they need the wise sovereignty of justice (11).

The behavior of university students is similar to that of the general population sampled at subway entrances, except for the lower prevalence of hard drugs, including opium, hashish, crystal, heroin, and ecstasy, but not LSD, and the lack of gender difference for cigarettes, alcohol, and psychiatrics. The same, albeit less gender-specific similarity, is evident in the sample of public parks for cigarettes and alcohol. Substance use was found to be primarily a male problem (12). Gender differences in rates of substance consumption have been consistently observed in the general population and treatment-seeking samples, with men exhibiting significantly higher rates of substance use, abuse, and dependence (13). The gender gap in the prevalence of substance use and onset of substance use disorders has significantly narrowed lately and may be attributable to social and cultural factors, while women are more vulnerable to the functional consequences and side effects (14, 15). The astonishing and tight gender similarity among students in our society signals a cultural reformation rooted in universities that reflects how the misperception of equity jeopardized femininity. Another observation regarding students is that although the differences between park visitors and the general population are the same among students from different sample groups, the longitudinal alteration for the public parks sample disappears among students, which can be inferred as immunity or delayed influenceability.

Finally, for hard drugs, there are three remarkable alterations in the comparison between the public parks sample and the general population: First, the shift in priority of opium and hashish; second, the dissociation of crystal and heroin, which are joint substances among the general population, while crystal outpaces in public parks; and third, the amazing boost of LSD followed by ecstasy among the public parks sample. All three indicate changing attitudes through the market. Basically, there is no agreement as to which psychoactive substances should be regarded as hard or soft drugs (16). Although such blurred terminology should be avoided in a scientific context, the hardness of a substance based on the subjective attitude of society might be an appropriate term to justify the difference in the prevalence of marijuana (16.0%) and hashish (4.5%), while both have almost the same pharmacological effects. By the way, the first remark may be the predictable consequence of the rise of cannabis; the second could be due to the changing cultivation policies in Afghanistan (8) or, together with the third, can be interpreted as an enthusiasm towards stimulants. In general, investigating hard drugs with such a subjective conceptualization requires a deep, comprehensive research design that integrates dynamic analysis of economic alternatives, psychosocial predictors, detailed interviews with consumers, trade transport conditions, political considerations, and official reports.

Footnotes

References

  • 1.
    Sarkhel S. Kaplan and Sadock's Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry. Indian J Psychiatry. 2009;51(4):331. [PubMed Central ID: PMC2802389].
  • 2.
    Heydari ST, Izedi S, Sarikhani Y, Kalani N, Akbary A, Miri A, et al. The Prevalence of Substance use and Associated Risk Factors Among University Students in the City of Jahrom, Southern Iran. Int J High Risk Behav Addict. 2015;4(2). e22381. [PubMed ID: 26097836]. [PubMed Central ID: PMC4464575]. https://doi.org/10.5812/ijhrba.4(2)2015.22381.
  • 3.
    Mozafarinia R, Assarian M, Ziaaddini A. Prevalence of Substance Abuse among Students of Tehran University of Medical Sciences, Iran. Addict Health. 2017;9(2):103-9. [PubMed ID: 29299213]. [PubMed Central ID: PMC5742417].
  • 4.
    World Health Organization. WHO global report on trends in prevalence of tobacco use 2000-2030. Geneva, Switzerland: World Health Organization; 2024, [cited 2025]. Available from: http://who.int/publications/i/item/9789240088283.
  • 5.
    Glantz MD, Bharat C, Degenhardt L, Sampson NA, Scott KM, Lim CCW, et al. The epidemiology of alcohol use disorders cross-nationally: Findings from the World Mental Health Surveys. Addict Behav. 2020;102:106128. [PubMed ID: 31865172]. [PubMed Central ID: PMC7416527]. https://doi.org/10.1016/j.addbeh.2019.106128.
  • 6.
    Manthey J, Freeman TP, Kilian C, Lopez-Pelayo H, Rehm J. Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates. Lancet Reg Health Eur. 2021;10:100227. [PubMed ID: 34806072]. [PubMed Central ID: PMC8589728]. https://doi.org/10.1016/j.lanepe.2021.100227.
  • 7.
    Wang Q, Qin Z, Xing X, Zhu H, Jia Z. Prevalence of Cannabis Use around the World: A Systematic Review and Meta-Analysis, 2000-2024. China CDC Wkly. 2024;6(25):597-604. [PubMed ID: 38933041]. [PubMed Central ID: PMC11196877]. https://doi.org/10.46234/ccdcw2024.116.
  • 8.
    World Health Organization. World drug report 2024 - Special points of interest. Geneva, Switzerland: World Health Organization; 2024.
  • 9.
    Negus SS. An economon model of drug addiction. Psychopharmacology (Berl). 2024;241(3):417-25. [PubMed ID: 38277005]. [PubMed Central ID: PMC10884072]. https://doi.org/10.1007/s00213-024-06535-7.
  • 10.
    Evans DG. In the Name of Policing the Drug War; How Many Liberties Are We Losing. Hum Rts. 1990;17.
  • 11.
    Alexander BK. The roots of addiction in free market society. In: Granfield R, Reinarman C, editors. Expanding addiction: Critical essays. Oxfordshire, UK: Routledge; 2014. p. 107-26.
  • 12.
    Tuchman E. Women and addiction: the importance of gender issues in substance abuse research. J Addict Dis. 2010;29(2):127-38. [PubMed ID: 20407972]. https://doi.org/10.1080/10550881003684582.
  • 13.
    Greenfield SF, Back SE, Lawson K, Brady KT. Substance abuse in women. Psychiatr Clin North Am. 2010;33(2):339-55. [PubMed ID: 20385341]. [PubMed Central ID: PMC3124962]. https://doi.org/10.1016/j.psc.2010.01.004.
  • 14.
    McHugh RK, Votaw VR, Sugarman DE, Greenfield SF. Sex and gender differences in substance use disorders. Clin Psychol Rev. 2018;66:12-23. [PubMed ID: 29174306]. [PubMed Central ID: PMC5945349]. https://doi.org/10.1016/j.cpr.2017.10.012.
  • 15.
    Agabio R, Campesi I, Pisanu C, Gessa GL, Franconi F. Sex differences in substance use disorders: focus on side effects. Addict Biol. 2016;21(5):1030-42. [PubMed ID: 27001402]. https://doi.org/10.1111/adb.12395.
  • 16.
    Janik P, Kosticova M, Pecenak J, Turcek M. Categorization of psychoactive substances into "hard drugs" and "soft drugs": a critical review of terminology used in current scientific literature. Am J Drug Alcohol Abuse. 2017;43(6):636-46. [PubMed ID: 28650668]. https://doi.org/10.1080/00952990.2017.1335736.

Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Purchasing Reprints

  • Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here (   https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.
Search Relations

Author(s):

Related Articles